Company Filing History:
Years Active: 2011-2015
Title: The Innovations of Detlef Oswald
Introduction
Detlef Oswald is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for gene expression inhibition and vaccine creation.
Latest Patents
Detlef Oswald holds 2 patents that showcase his expertise and innovative spirit. His latest patents include:
1. **DNA constructs for specific inhibition of gene expression by RNA interference** - This invention relates to expression constructs designed for the targeted inhibition of gene expression. The method, which requires no PCR steps, is executed in a single reaction vessel within a few hours and is suitable for inhibiting multiple gene expressions.
2. **Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat** - This invention concerns a vaccine that provides protection against diseases resulting from lentivirus infections, particularly the Feline Leukosis virus. The vaccine comprises codon-optimized DNA sequences that encode structural proteins and the crucial membrane protein of FeLV.
Career Highlights
Detlef Oswald is associated with Mologen AG, a company that focuses on developing innovative therapeutic solutions. His work has significantly impacted the field of gene therapy and vaccine development.
Collaborations
Detlef has collaborated with notable colleagues such as Matthias Schroff and Claas Junghans, contributing to advancements in their shared field of expertise.
Conclusion
Detlef Oswald's contributions to biotechnology through his patents and work at Mologen AG highlight his role as an influential inventor. His innovative approaches to gene expression and vaccine development continue to pave the way for future advancements in medical science.